𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of fludarabine-refractory chronic lymphocytic leukemia

✍ Scribed by Apostolia-Maria Tsimberidou; Michael J. Keating

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
163 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Enhancing the action of rituximab by add
Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia
✍ Wei Xu; Kou-Rong Miao; Dan-Xia Zhu; Cheng Fang; Hua-Yuan Zhu; Hua-Jie Dong; Dong πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 280 KB

## Abstract Complement deficiencies have been identified in many chronic lymphocytic leukemia (CLL) patients. Supplying fresh frozen plasma (FFP)‐derived complement can enhance complement‐dependent cell lysis by the rituximab. The objective of our study was to evaluate the clinical efficacy and saf

Fludarabine and cytosine arabinoside in
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia
✍ Samer Suki; Hagop Kantarjian; Varsha Gandhi; Elihu Estey; Susan O'Brien; Milosla πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 571 KB

## Background: The objectives of the study were to evaluate the antileukemic efficacy and toxicity profiles of the combination of fludarabine and intermediate-dose cytosine arabinoside (ara-c) in refractory or relapsed adult acute lymphocytic leukemia (all). patients and methods. thirty adults with

Fludarabine and mitoxantrone for patient
Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia
✍ Apostolia M. Tsimberidou; Michael J. Keating; Francis J. Giles; William G. Wierd πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 481 KB

## Abstract ## BACKGROUND The objective of the current study was to assess the efficacy of combination therapy with fludarabine and mitoxantrone in patients with B‐cell chronic lymphocytic leukemia (CLL). ## METHODS Eighty‐eight patients were treated with fludarabine 30 mg/m^2^ intravenously dai